Navigation Links
Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
Date:12/20/2012

Saranac Lake, New York (PRWEB) December 20, 2012

Trudeau Institute faculty member Stephen T. Smiley, Ph.D., has been awarded a grant to evaluate new strategies for improving patient survival after a bacterial infection. If successful, his strategy would work against many types of serious infections that spread throughout the body, including those caused by deadly weaponized or antibiotic-resistant bacteria. The research will be funded by a grant from the National Institute of Allergy and Infectious Diseases (NIAID), via the Northeast Biodefense Center. The studies will advance NIAID goals by defining basic principles of immunity while advancing a new, broadly applicable paradigm for the treatment of life-threatening bacterial infections.

The Research Project
Supplying immune defense therapeutically, by injecting patients with protective antibodies, can be an effective treatment for life-threatening infections. This ‘immunotherapy’ may be the best treatment option for infections caused by antibiotic-resistant bacteria. However, it can be difficult, and costly, to deliver sufficiently high quantities of antibodies to human patients. Moreover, antibodies often fail to stop bacterial infections immediately. Rather, they typically slow bacterial growth, thus providing time for the patient’s immune system to ramp up and clear the infection.

Given the relatively slow clearance of bacterial infections by immunotherapy, co-treatments that suppress damage caused by infections should synergize with immunotherapy to improve overall survival. Much of the damage caused by bacterial infections is caused by sepsis, an infection-induced syndrome characterized by excessive inflammation and dysregulated coagulation. Despite its potential to cause damage, Dr. Smiley’s prior studies establish that coagulation also can be essential for immune defense against bacteria. This observation suggests that sepsis therapeutics should strive to control, but not completely prevent, coagulation.

This new funding from the Northeast Biodefense Center will help Dr. Smiley test the hypothesis that treatments that reduce coagulation will synergize with low-dose immunotherapy to improve survival during bacterial infection.

About the Northeast Biodefense Center
Founded in 2003 and headquartered at Columbia University in the City of New York, the Northeast Biodefense Center (NBC) is a consortium of academic and governmental biomedical research institutions from New York State, New Jersey, Connecticut, and strategic partners in other states. NBC is one of eight U.S. Department of Health and Human Services-designated regional biodefense centers.

About the Trudeau Institute
The Trudeau Institute is a nonprofit biomedical research center founded in 1884 by Dr. E.L. Trudeau. The Institute's fundamental research on immunity fosters the development of vaccines, treatments and cures for many life-threatening diseases, including cancer, tuberculosis and influenza. The Institute is supported by federal and state grants and contributions from individuals, private foundations and corporations. For further information about the Trudeau Institute, go to http://www.trudeauinstitute.org.

###

Press Contact
Kim Godreau
Trudeau Institute
kgodreau(at)trudeauinstitute(dot)org
(518) 891-3080, ext. 561

Read the full story at http://www.prweb.com/releases/2012/12/prweb10258569.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The Veterinary Bioscience Institute's 2012 Year in Review
2. Veterinary Bioscience Institute (VBI) and a-tune software, Inc. Partnership
3. Harvards Wyss Institute team creates versatile 3d nanostructures using DNA bricks
4. Craft Beverage Institute of the Southeast Formed at A-B Tech
5. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
6. First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After Injury
7. Harvards Wyss Institute models a human disease in an organ-on-a-chip
8. Van Andel Institute Research Symposium Showcases Latest Developments In Parkinsons Research
9. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
10. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
11. Scripps Research Institute scientists find easier way to make new drug compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA ... dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at ... of the trial was to determine the safety, antitumor activity, and recommended phase ...
(Date:12/7/2016)... LANSING, Mich. , Dec. 7, 2016 ... it has named Dr. Dan Kephart as ... the company. Kephart will assume his responsibilities at Neogen ... research and development director for the agribusiness unit of ... food safety development at Life Technologies. His extensive industry ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
(Date:11/15/2016)... Research and Markets has announced the addition of the "Bioinformatics ... ... The global bioinformatics market is projected ... in 2016, growing at a CAGR of 21.1% during the forecast ... by the growing demand for nucleic acid and protein sequencing, increasing ...
Breaking Biology News(10 mins):